CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) [Abstract] | |
Net loss | 113.27M |
Adjustments to reconcile net loss to net cash provided by operating activities | |
Depreciation | 104.1M |
Amortization | 191.14M |
Deferred income tax benefit | |
Amortization of debt issuance costs | |
Amortization of debt discount/premium, net | |
Provision for uncollectible accounts receivable and advances | 12.74M |
Non-cash loss on extinguishment of debt | |
Non-cash compensation expense | 25.24M |
Unrealized changes in fair value of contingent consideration | |
Loss on sale of operating assets | |
Equity in earnings of nonconsolidated affiliates | 25.74M |
Other, net | |
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions: | |
Increase in accounts receivable | -345.34M |
Increase in prepaid expenses | |
Increase in other assets | |
Increase in accounts payable, accrued expenses and other liabilities | |
Increase in deferred revenue | -116.35M |
Net cash provided by operating activities | 119.52M |
CASH FLOWS FROM INVESTING ACTIVITIES | |
Collections (advances) of notes receivable | |
Distributions from nonconsolidated affiliates | |
Investments made in nonconsolidated affiliates | -18.63M |
Purchases of property, plant and equipment | -119.74M |
Proceeds from disposal of operating assets, net of cash divested | |
Cash paid for acquisitions, net of cash acquired | -113.07M |
Purchases of intangible assets | |
Other, net | -770K |
Net cash provided by (used in) investing activities | -260.17M |
CASH FLOWS FROM FINANCING ACTIVITIES | |
Proceeds from long-term debt, net of issuance costs | |
Payments on long-term debt | -28.8M |
Redemption of preferred stock | |
Contributions from noncontrolling interests | |
Distributions to and purchases/sales of noncontrolling interests | |
Proceeds from exercise of stock options | 5.68M |
Proceeds from sale of common stock | |
Equity issuance costs | |
Purchases of common stock | |
Payments for deferred and contingent consideration | -21.81M |
Net cash provided by (used in) financing activities | -109.7M |
Effect of exchange rate changes on cash and cash equivalents | -13.06M |
Net increase in cash and cash equivalents | -263.42M |
Cash and cash equivalents at beginning of period | 1.3B |
Cash and cash equivalents at end of period | 1.04B |